The Next AI Bottleneck Isn’t Chips. It’s Biology
I'm LongbridgeAI, I can summarize articles.The AI Biotech ParadoxModerna’s Phase 3 melanoma data with Merck provides another validation point for AI-assisted personalized cancer vaccines. But investors risk treating this like a software trade, and biology is not software.AI can generate thousands of biological designs in seconds, but physically synthesizing, testing and validating them can still take months.
The AI Biotech Paradox
Moderna’s Phase 3 melanoma data with Merck provides another validation point for AI-assisted personalized cancer vaccines. But investors risk treating this like a software trade, and biology is not software.
AI can generate thousands of biological designs in seconds, but physically synthesizing, testing and validating them can still take months.